UA84737C2 - Imidazoline derivatives having cb1-antagonistic activity - Google Patents
Imidazoline derivatives having cb1-antagonistic activityInfo
- Publication number
- UA84737C2 UA84737C2 UAA200610009A UAA200610009A UA84737C2 UA 84737 C2 UA84737 C2 UA 84737C2 UA A200610009 A UAA200610009 A UA A200610009A UA A200610009 A UAA200610009 A UA A200610009A UA 84737 C2 UA84737 C2 UA 84737C2
- Authority
- UA
- Ukraine
- Prior art keywords
- imidazoline derivatives
- antagonistic activity
- compounds
- preparation
- methods
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
The present invention relates to 1,2,4-tri-substituted imidazoline derivatives, to methods for the preparation of these compounds, to novel intermediates useful for the synthesis of said imidazoline derivatives, to methods for the preparation of these intermediates, to pharmaceutical compositions containing one or more of these imidazoline derivatives as active ingredient, as well as to the use of these pharmaceutical compositions for the treatment of psychiatric and neurological disorders. The compounds have the general formula (I) wherein the symbols have the meaningsgiven in the specification.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04100656 | 2004-02-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA84737C2 true UA84737C2 (en) | 2008-11-25 |
Family
ID=34928876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200610009A UA84737C2 (en) | 2004-02-19 | 2005-02-16 | Imidazoline derivatives having cb1-antagonistic activity |
Country Status (7)
Country | Link |
---|---|
CN (1) | CN101076520B (en) |
AR (1) | AR047613A1 (en) |
BR (1) | BRPI0507269A (en) |
SA (1) | SA05260008B1 (en) |
TW (1) | TWI335321B (en) |
UA (1) | UA84737C2 (en) |
ZA (1) | ZA200606123B (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1429761T1 (en) * | 2001-09-21 | 2007-02-28 | Solvay Pharm Bv | Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
TWI231757B (en) * | 2001-09-21 | 2005-05-01 | Solvay Pharm Bv | 1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity |
AR038966A1 (en) * | 2002-03-18 | 2005-02-02 | Solvay Pharm Bv | DERIVATIVES OF TIAZOL THAT HAVE ANTAGONIST, AGONIST OR PARTIAL AGONIST ACTIVITY OF CB1 |
US6878735B2 (en) * | 2002-05-31 | 2005-04-12 | Board Of Trustees Of Michigan State University | Multi-substituted imidazolines and method of use thereof |
-
2005
- 2005-02-14 AR ARP050100514 patent/AR047613A1/en not_active Application Discontinuation
- 2005-02-14 TW TW94104182A patent/TWI335321B/en not_active IP Right Cessation
- 2005-02-16 BR BRPI0507269-7A patent/BRPI0507269A/en not_active IP Right Cessation
- 2005-02-16 SA SA05260008A patent/SA05260008B1/en unknown
- 2005-02-16 UA UAA200610009A patent/UA84737C2/en unknown
- 2005-02-16 CN CN2005800033771A patent/CN101076520B/en not_active Expired - Fee Related
-
2006
- 2006-07-24 ZA ZA200606123A patent/ZA200606123B/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW200530191A (en) | 2005-09-16 |
CN101076520A (en) | 2007-11-21 |
SA05260008A (en) | 2005-12-03 |
CN101076520B (en) | 2011-06-01 |
BRPI0507269A (en) | 2007-06-26 |
ZA200606123B (en) | 2007-11-28 |
AR047613A1 (en) | 2006-01-25 |
TWI335321B (en) | 2011-01-01 |
SA05260008B1 (en) | 2007-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL176546A0 (en) | Imidazoline derivatives having cb1-antagonistic activity | |
MY140693A (en) | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
MY148480A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
TW200517388A (en) | Thiazole derivatives as cannabinoid receptor modulators | |
TW200635903A (en) | Therapeutic agents | |
MY138478A (en) | Benzazepine derivatives for the treatment of neurological disorders | |
AP1822A (en) | Substituted pyridinones as modulators of P38 MAP kinase. | |
TW200531689A (en) | Therapeutic agents | |
IL187438A0 (en) | Pyrrolopyridine derivatives and pharmaceutical compositions containing the same | |
TW200504034A (en) | Therapeutic agents | |
TW200503713A (en) | Novel compounds | |
TW200503710A (en) | Novel compounds | |
UA92503C2 (en) | 5-(phenylisoxazolylethoxy)-triazol-3-yl-substituted pyridine compounds for the treatment of neurological, psychiatric or pain disorders | |
TW200633986A (en) | Therapeutic agents | |
WO2004009549A3 (en) | Piperidines useful for the treatment of central nervous system disorders | |
TW200611695A (en) | Pyrrolopyridine derivatives | |
HK1069169A1 (en) | Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors | |
GB0513886D0 (en) | Novel compounds | |
TW200514781A (en) | Novel compounds | |
TW200509933A (en) | Therapeutic agents | |
UA84896C2 (en) | Hydronopol derivatives as agonists on human orl1 receptors | |
TW200734324A (en) | Therapeutic agents | |
EP1736470A3 (en) | Pyrimidine derivatives as CB2 cannabinoid receptor modulators | |
MXPA05004273A (en) | Phenylalkyl and pyridylalkyl piperazine derivatives. | |
IL173436A0 (en) | 1h-imidazole derivatives as cannabinoid receptor modulators |